» Articles » PMID: 27129760

Hospital, Patient, and Clinical Factors Influence 30- and 90-Day Readmission After Primary Total Hip Arthroplasty

Overview
Journal J Arthroplasty
Specialty Orthopedics
Date 2016 May 1
PMID 27129760
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to analyze the hospital, clinical, and patient factors associated with inpatient readmission after total hip arthroplasty (THA) in the Medicare population and to understand the primary reasons for readmission.

Methods: The Medicare 100% national hospital claims database was used to identify 442,333 older patients (65+) with a primary THA in 3730 hospitals between 2010 and 2013. A multilevel logistic regression analysis with a clustered data structure was used to investigate the risk of all-cause 30- and 90-day readmission, incorporating hospital, clinical, and patient factors.

Results: At 30 days, 5.8% (median) of the patients were readmitted, whereas at 90 days, 10.5% (median) were readmitted. Geographic census region, hospital procedure volume, and nonprofit ownership were the only significant hospital factors among those we studied. Overall, clinical factors explained more of the variation in readmission rates than general hospital factors. Use of a perioperative transfusion was associated with 14% greater risk, patients discharged to home had 28% lower risk, and surgeon volume and length of stay were also significant risk factors. The top 5 most frequently reported primary reasons for 30-day readmission in THA were procedure related: dislocation (5.9%), deep infection (5.1%), wound infection (4.8%), periprosthetic fracture (4.4%), or hematoma (3.4%).

Conclusion: These findings support further optimization of the delivery of care-both intraoperative and postoperative-to reduce the broad variation in hospital readmissions.

Citing Articles

Revision total hip arthroplasty for periprosthetic fracture: epidemiology, outcomes, and factors associated with success.

Morgan S, Bourget-Murray J, Garceau S, Grammatopoulos G Ann Jt. 2024; 8:30.

PMID: 38529253 PMC: 10929400. DOI: 10.21037/aoj-23-16.


Trends, complications, and readmission of allogeneic red blood cell transfusion in primary total hip arthroplasty in china: a national retrospective cohort study.

Jiang Q, Wang Y, Xie D, Wei J, Li X, Zeng C Arch Orthop Trauma Surg. 2023; 144(1):483-491.

PMID: 37737901 DOI: 10.1007/s00402-023-05051-1.


Cemented versus Cementless Femoral Fixation for Elective Primary Total Hip Arthroplasty: A Nationwide Analysis of Short-Term Complication and Readmission Rates.

Chen X, Christ A, Chung B, Ton A, Ballatori A, Shahrestani S J Clin Med. 2023; 12(12).

PMID: 37373640 PMC: 10299501. DOI: 10.3390/jcm12123945.


No Difference in Dislocation Rates Comparing DMC-THA for Displaced Femoral Neck Fracture and for Osteoarthritis-A Matched-Pair Analysis.

Regennass L, Brulefert K, Feuillet F, Nich C Indian J Orthop. 2023; 57(3):436-444.

PMID: 36825264 PMC: 9941398. DOI: 10.1007/s43465-023-00816-7.


An Increase in Same-day Discharge After Total Joint Arthroplasty During the COVID-19 Pandemic Does Not Influence Patient Outcomes: A Retrospective Cohort Analysis.

Mitchell B, Cleary L, Samuel L, Coobs B, Thomas M, Martinkovich S Arthroplast Today. 2023; 20:101115.

PMID: 36776732 PMC: 9905097. DOI: 10.1016/j.artd.2023.101115.